Posts Tagged: "patent infringement"

Justices Won’t Consider Whether CAFC’s Claim Construction Constitutes a Judicial Taking

The U.S. Supreme Court today denied a petition that asked it to consider whether the U.S. Court of Appeals for the Federal Circuit’s (CAFC’s) “construction of petitioner’s patent claim was unforeseeable and unjustifiable under the circuit’s prior decisions,” thereby constituting a judicial taking of property in violation of the Fifth Amendment’s Takings Clause. The petition was an appeal from the CAFC’s April decision affirming a district court’s judgment that AT&T Mobility LLC did not infringe an inventor’s wireless communications technology patent but also holding that AT&T had forfeited its chance to prove the patent invalid on appeal.

Build a Consumer Base with Innovation; Protect Sales with Design Patents

The United States Patent and Trademark Office (USPTO) issued its one millionth design patent on September 26, 2023. U.S. Patent No. D1,000,000 claims the ornamental design for a dispensing comb. This milestone comes during a particularly prolific period for design patents. In 2022 alone, the USPTO received more than 50,000 design patent applications. The Office has seen a 20% growth in design patent applications over the last five years. It is not hard to understand why inventors are seeking design patent protection at previously unseen levels. In an age of complicated technologies, design patents can protect marketable appearances of products in the same manner generally as trademarks identify source. Understanding design patent benefits underlying the recent growth in application numbers is a good lesson for businesses seeking to distinguish a brand—but keep an eye out for further developments and be prepared to adjust business and IP strategies.

CAFC Says Lack of Concrete Plans to Market Eye Treatment Dooms Allgenesis Appeal

On November 7, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Allgenesis Biotherapeutics Inc. v. Cloudbreak Therapeutics, LLC, dismissing Allgenesis’ appeal after an unsuccessful challenge to Cloudbreak’s patent claims at the Patent Trial and Appeal Board (PTAB). The Federal Circuit ruled that Allgenesis lacked Article III standing to bring the appeal for failing to establish an injury in fact stemming from potential infringement liability or the impact of the PTAB’s priority determinations on the scope of Allgenesis’ patent rights.

CAFC Orders Review of Extrinsic Evidence to Determine Proper Limit of Claimed pH Range

Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia. The Federal Circuit remanded the case for further consideration of extrinsic evidence from chemistry textbooks to determine the proper meaning of the claim term “a pH of 13 or higher.”

Federal Circuit Weighs in on Parameters for Prosecution Disclaimer

The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential decision holding that a Delaware district court erred in its claim construction of a term with respect to Malvern Panalytical, Inc.’s patents. Specifically, the CAFC said the district court erred by relying heavily on the patent prosecution history statements for a related patent that had been cited in the information disclosure statement (IDS) during supplemental examination of one of the patents-in-suit to inform its construction of the term in question.

Varsity Sponsors

IPWatchdog Events

PTAB Masters™ 2024
January 29, 2024 @ 5:00 pm - January 31, 2024 @ 2:00 pm EST
Artificial Intelligence Masters™ 2024
March 4, 2024 @ 4:00 pm - March 6, 2024 @ 2:00 pm EST
International Intellectual Property Masters™ 2024
April 8, 2024 @ 4:00 pm - April 10, 2024 @ 4:00 pm EDT
Patent Litigation & Licensing Masters™ 2024: Patent Assertion & Enforcement
May 13, 2024 @ 4:00 pm - May 15, 2024 @ 4:00 pm EDT
Patent Prosecution Masters™ 2024
June 24, 2024 @ 4:00 pm - June 26, 2024 @ 2:00 pm EDT

From IPWatchdog